Quantcast
Last updated on April 19, 2014 at 7:40 EDT

Latest MetaStat Inc. Stories

2014-02-18 08:29:52

NEW YORK, Feb. 18, 2014 /PRNewswire/ -- New trial confirms MetaSite Breast test's ability to predict breast cancer metastasis. MetaSite Breast would allow doctors and patients to customize breast cancer treatment based on the cancer's probability of metastasizing. Life sciences company MetaStat, Inc. (OTCQB: MTST) recently completed a trial of its MetaSite Breast test that confirmed the test's ability to accurately predict whether breast cancer would metastasize. The confirmation...

2014-02-17 08:24:57

NEW YORK, Feb. 17, 2014 /PRNewswire/ -- With the tremendous run in the biotech sector over the last 12 months many have overlooked this micro-cap gem that has terrific upside potential. Metastat, Inc. (OTCQB: MTST) is a life sciences company that provides proprietary platform technologies for the treatment of systemic metastasis. This micro-cap stock is topping the list for many analyst in the coming year. Metastat has all characteristics that a smart investor would look for in a...

2013-04-23 08:29:10

NEW YORK, April 23, 2013 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued a Quarterly Update on MetaStat, Inc. (OTCBB: MTST). The Quarterly Update summarizes MetaStat's recent financial results and highlights key accomplishments that have occurred since the base Executive Informational Overview(®) (EIO) was published on January 3, 2013. Both MetaStat's Quarterly Update and base EIO can be found at www.crystalra.com. MetaStat, Inc. ("MetaStat" or "the...

2013-04-15 08:30:15

MONTCLAIR, N.J., April 15, 2013 /PRNewswire/ -- MetaStat, Inc. (OTCBB: MTST), a life science company focused on understanding and treating systemic metastasis, announced today the appointment of David Epstein, Ph.D. as Advisor for MetaStat's Drug Discovery & Development efforts. In addition, MetaStat intends to appoint Dr. Epstein to MetaStat's board of directors as soon as practicable. Dr. Epstein brings tremendous expertise to MetaStat at a pivotal time in the company's evolution....

2013-02-26 12:28:19

MONTCLAIR, N.J., Feb. 26, 2013 /PRNewswire/ -- MetaStat, Inc. (OTCBB: MTST), ("MetaStat" or the "Company"), a life science company focused on understanding and treating systemic metastasis, announced today that the Company has been granted eligibility status by the Depository Trust Corporation ("DTC") as of February 20, 2013. DTC is a subsidiary of the Depository Trust & Clearing Corporation and manages the electronic clearing and settlement of publicly traded companies. Securities that...

2013-01-18 08:23:32

MONTCLAIR, N.J., Jan. 18, 2013 /PRNewswire/ -- MetaStat, Inc. (OTCBB: MTST), ("MetaStat" or the "Company"), a life science company focused on understanding and treating systemic metastasis, today announced that the Company will be presenting at the NINE 2013 - Noble Financial Capital Markets' Ninth Annual Equity Conference held at the Hard Rock Hotel & Casino, Hollywood, Florida, on Tuesday, January 22, 2013 at 4:30 p.m. Eastern Time. Dr. Oscar Bronsther, Chief Executive Officer and...

2013-01-07 16:23:31

NEW YORK, Jan. 7, 2013 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(®) (EIO) on MetaStat, Inc. (MTST-OTC.BB). The full 52-page report can be found at www.crystalra.com. MetaStat, Inc. ("MetaStat" or "the Company") develops next-generation diagnostic and therapeutic products for metastatic cancer--cancer that has spread from a primary tumor to other areas of the body. The Company's pipeline is based on over 15...

2013-01-07 08:28:13

MONTCLAIR, N.J., Jan. 7, 2013 /PRNewswire/ -- MetaStat, Inc. (OTCBB: MTST), ("MetaStat" or the "Company"), a life science company focused on understanding and treating systemic metastasis, announced today that a 500 patient trial in breast cancer has been completed. The trial was completed on time and on budget in line with previously disclosed expectations and the company expects the full analysis and publication of the data later in the year. According to Dr. Oscar Bronsther, Chief...

2013-01-03 16:23:32

MONTCLAIR, N.J., Jan. 3, 2013 /PRNewswire/ -- MetaStat, Inc. (OTCQB: MTST), ("MetaStat" or the "Company"), a life science company focused on understanding and treating systemic metastasis today announced that Warren C. Lau, President of MetaStat, will be presenting at the Biotech Showcase conference in San Francisco on Monday, January 7, 2013. The presentation schedule is as follows: Conference: Biotech Showcase 2013Date: Monday, January 7, 2013Location: Parc 55 WyndhamTime: 3:45 P.M. PST...

2012-12-04 12:25:53

MONTCLAIR, N.J., Dec. 4, 2012 /PRNewswire/ -- MetaStat, Inc. ("MetaStat" or the "Company") (OTCBB: MTST), a life science company focused on understanding and treating systemic metastasis, today announced that John S. Condeelis, Ph.D., Chairman of MetaStat's Scientific Advisory Board, and Joan Jones, M.D., a member of MetaStat's Clinical Advisory Board, will be presenting data on the Company's licensed metastatic breast cancer markers at the CTRC-AACR 2012 San Antonio Breast Cancer Symposium...